跳至主要内容
临床试验/JPRN-UMIN000007314
JPRN-UMIN000007314已完成未知

The effect of pyridoxine for prevention of hand-foot syndrome in colon cancer patients with adjuvant chemotherapy using capecitabine: a randomized study - The effect of pyridoxine for prevention of hand-foot syndrome

Yokohama City University0 个研究点目标入组 70 人开始时间: 2012年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Pregnant or lactating, or planning to become pregnant. (15) History of hypersensitivity or severe adverse reaction to fluoropyrimidines. (3) Serious concurrent disease [including interstitial pneumonia, pulmonary fibrosis, intestinal paralysis, ileus, poorly controlled diabetes, liver cirrhosis or hepatitis (type B or C), history of myocardial infarction or unstable angina within past 6 months]. (4) Active multiple primary cancer (disease-free less than 5 years). (5) Concurrent infectious disease. (6) Judged to be unsuitable for participation in the clinical study by the investigator for any other reason.

研究者

相似试验